Y. Lis
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Pharmaceutical Science top 5%
- Drug Solubulity and Delivery Systems
Papers in
-
- Heart Failure Treatment and Management 2
- Cardiac electrophysiology and arrhythmias 1
- Co-authors
- SR Walker (2 shared papers)Jeff J. Guo (2 shared papers)Dennis W. Raisch (2 shared papers)Boyang Bian (1 shared paper)John Doyle (1 shared paper)Roderick A.F. MacLeod (1 shared paper)Hans G. Drexler (1 shared paper)E. Becker (1 shared paper)
- Journals
- Value in Health (3 papers)Pharmacoepidemiology and Drug Safety (2 papers)British Journal of Clinical Pharmacology (2 papers)Biochemical Journal (2 papers)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Y. Lis
16 papers receiving 924 citations
Y. Lis's Hit Papers
Peers
Comparison fields: 5 of 122
- Pharmacology 122
- Pharmaceutical Science 77
- Computational Theory and Mathematics 120
- Toxicology 24
- Orthopedics and Sports Medicine 45
Countries citing papers authored by Y. Lis
This map shows the geographic impact of Y. Lis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Lis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Lis more than expected).
Fields of papers citing papers by Y. Lis
This network shows the impact of papers produced by Y. Lis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Lis. The network helps show where Y. Lis may publish in the future.
Co-authors
The 25 scholars most cited alongside Y. Lis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Pharmaceutical innovation by the seven UK‐owned pharmaceutical companies (1964‐1985). Hit paper breakdown → | 1988 | 338 |
| 2 | 2010 | 150 | |
| 3 | 1995 | 109 | |
| 4 | 2002 | 103 | |
| 5 | 1987 | 62 | |
| 6 | 2006 | 54 | |
| 7 | 1984 | 49 | |
| 8 | 1978 | 33 | |
| 9 | 2012 | 29 | |
| 10 | 1977 | 25 | |
| 11 | 1993 | 16 | |
| 12 | 1989 | 11 | |
| 13 | 1977 | 8 | |
| 14 | 1993 | 3 | |
| 15 | 2011 | 1 | |
| 16 | 1988 | 1 |
About Y. Lis
Y. Lis is a scholar working on Cardiology and Cardiovascular Medicine, Economics and Econometrics, Surgery, Genetics and Pharmacology, having authored 16 papers that have together received 992 indexed citations. Recurring topics across this work include Hemodynamic Monitoring and Therapy (2 papers), Heart Failure Treatment and Management (2 papers), Science, Research, and Medicine (2 papers), Iron Metabolism and Disorders (2 papers), Cardiac electrophysiology and arrhythmias (1 paper), Twentieth Century Scientific Developments (1 paper), Osteoarthritis Treatment and Mechanisms (1 paper) and Pharmaceutical industry and healthcare (1 paper). The work is most often cited by research in Pharmacology (122 citations), Pharmaceutical Science (77 citations), Computational Theory and Mathematics (120 citations), Toxicology (24 citations) and Orthopedics and Sports Medicine (45 citations). Y. Lis has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include SR Walker, Jeff J. Guo, Dennis W. Raisch, Boyang Bian, John Doyle, Roderick A.F. MacLeod, Hans G. Drexler, E. Becker, Roger Williams and Adrian Bomford. Their work appears in journals such as Value in Health, Pharmacoepidemiology and Drug Safety, British Journal of Clinical Pharmacology, Biochemical Journal and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.